Drug Search Results
More Filters [+]

Nebentan

Alternative Names: nebentan, ym-598, ym598, ym 598
Latest Update: 2012-06-07
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: ETa Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Astellas Pharma
Company Location: NEW YORK NY 10005
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Nebentan

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Prostate Cancer

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

598-CL-008

P2

Terminated

Prostate Cancer

None

598-CL-004

P2

Terminated

Prostate Cancer

None

Recent News Events

Date

Type

Title